BCB
BMY icon

Brian C. Broderick’s Bristol-Myers Squibb BMY Stock Holding History

Brian C. Broderick’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$614K Hold
10,117
– – 0.11% 70
2025
Q4 		$546K Hold
10,117
– – 0.1% 65
2025
Q3 		$456K Hold
10,117
– – 0.09% 70
2025
Q2 		$468K Hold
10,117
– – 0.09% 70
2025
Q1 		$617K Sell
10,117
-1,700
-14% -$99.1K 0.13% 62
2024
Q4 		$668K Hold
11,817
– – 0.13% 60
2024
Q3 		$611K Hold
11,817
– – 0.12% 62
2024
Q2 		$491K Sell
11,817
-1,450
-11% -$64.9K 0.1% 68
2024
Q1 		$719K Buy
13,267
+1,467
+12% +$74.7K 0.15% 65
2023
Q4 		$605K Buy
11,800
+100
+0.9% +$5.25K 0.15% 58
2023
Q3 		$679K Hold
11,700
– – 0.19% 55
2023
Q2 		$748K Hold
11,700
– – 0.2% 51
2023
Q1 		$811K Hold
11,700
– – 0.23% 48
2022
Q4 		$842K Hold
11,700
– – 0.25% 50
2022
Q3 		$832K Hold
11,700
– – 0.26% 50
2022
Q2 		$901K Hold
11,700
– – 0.27% 50
2022
Q1 		$854K Hold
11,700
– – 0.22% 54
2021
Q4 		$729K Hold
11,700
– – 0.18% 54
2021
Q3 		$692K Hold
11,700
– – 0.18% 57
2021
Q2 		$782K Hold
11,700
– – 0.21% 53
2021
Q1 		$739K Hold
11,700
– – 0.21% 51
2020
Q4 		$726K Hold
11,700
– – 0.22% 51
2020
Q3 		$705K Sell
11,700
-670
-5% -$40.3K 0.22% 54
2020
Q2 		$728K Hold
12,370
– – 0.24% 58
2020
Q1 		$689K Sell
12,370
-25
-0.2% -$1.53K 0.27% 54
2019
Q4 		$795K Buy
12,395
+470
+4% +$26.9K 0.26% 55
2019
Q3 		$605K Sell
11,925
-100
-0.8% -$4.7K 0.21% 58
2019
Q2 		$545K Sell
12,025
-1,296
-10% -$60.4K 0.19% 58
2019
Q1 		$636K Sell
13,321
-224
-2% -$11.2K 0.23% 57
2018
Q4 		$704K Hold
13,545
– – 0.3% 56
2018
Q3 		$840K Sell
13,545
-1,000
-7% -$59.3K 0.28% 55
2018
Q2 		$805K Sell
14,545
-50
-0.3% -$2.7K 0.29% 59
2018
Q1 		$924K Sell
14,595
-175
-1% -$11.3K 0.35% 58
2017
Q4 		$905K Sell
14,770
-7,470
-34% -$467K 0.33% 58
2017
Q3 		$1.42M Sell
22,240
-3,500
-14% -$204K 0.51% 55
2017
Q2 		$1.43M Sell
25,740
-510
-2% -$27.8K 0.53% 54
2017
Q1 		$1.43M Sell
26,250
-500
-2% -$27.4K 0.58% 48
2016
Q4 		$1.56M Sell
26,750
-700
-3% -$38.3K 0.68% 43
2016
Q3 		$1.48M Sell
27,450
-1,578
-5% -$101K 0.63% 46
2016
Q2 		$2.14M Sell
29,028
-350
-1% -$24.7K 0.9% 36
2016
Q1 		$1.88M Sell
29,378
-200
-0.7% -$12.6K 0.81% 40
2015
Q4 		$2.04M Buy
29,578
+4,500
+18% +$297K 0.91% 37
2015
Q3 		$1.48M Hold
25,078
– – 0.69% 52
2015
Q2 		$1.67M Sell
25,078
-389
-2% -$25.6K 0.71% 51
2015
Q1 		$1.64M Buy
25,467
+867
+4% +$54.3K 0.68% 51
2014
Q4 		$1.45M Sell
24,600
-156
-0.6% -$8.8K 0.62% 55
2014
Q3 		$1.27M Buy
24,756
+156
+0.6% +$7.79K 0.56% 59
2014
Q2 		$1.19M Sell
24,600
-100
-0.4% -$4.93K 0.55% 55
2014
Q1 		$1.28M Sell
24,700
-500
-2% -$26.6K 0.63% 52
2013
Q4 		$1.34M Hold
25,200
– – 0.67% 52
2013
Q3 		$1.17M Hold
25,200
– – 0.65% 49
2013
Q2 		$1.13M Buy
+25,200
New +$1.09M 0.67% 50

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brian C. Broderick's BMY Position: Q1 2026 in Review

Brian C. Broderick held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 10,117 shares worth $614K. The position accounts for 0.11% of the portfolio, ranked #70.

Brian C. Broderick first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.14M in Q2 2016. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Brian C. Broderick held 10,117 shares of Bristol-Myers Squibb worth $614K as of Q1 2026.
  • Brian C. Broderick left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.11% of Brian C. Broderick's portfolio in Q1 2026, its #70 holding.
  • Brian C. Broderick first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Brian C. Broderick's Bristol-Myers Squibb position peaked at $2.14M in Q2 2016.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Brian C. Broderick's 13F filing for Q1 2026, filed 7 May 2026.